...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Traditional and Complementary Medicine >Exploratory studies on the therapeutic effects of Kumarabharana Rasa in the management of chronic tonsillitis among children at a tertiary care hospital of Karnataka
【24h】

Exploratory studies on the therapeutic effects of Kumarabharana Rasa in the management of chronic tonsillitis among children at a tertiary care hospital of Karnataka

机译： kumarabharana rasa 在Karnataka三级护理医院慢性扁桃体炎中慢性扁桃体炎管理中的探索性研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The effect of an Ayurvedic poly-herbo-mineral formulation Kumarabharana Rasa (KR) in the management of chronic tonsillitis ( Tundikeri ) in children has been assessed in this study. This clinical study was a double-arm study with a pre- and post-test design at the outpatient level in a tertiary Ayurveda hospital attached to a teaching institute located in district headquarters in Southern India. Patients ( n ?=?40) with chronic tonsillitis satisfying diagnostic criteria and aged between 5 and 10 years were selected from the outpatient Department of Kaumarbhritya, SDM College of Ayurveda and Hospital, Hassan. Among them, 20 patients were treated with Kumarabharana rasa (tablet form) at a dose of 500?mg once daily for 30 days (Group A). The other 20 patients were treated with Godhuma Vati (placebo) at a dose of 500?mg once daily for 30 days (Group B). In both groups, Madhu was the Anupana advised. After completion of 30 days of treatment, the patients were assessed on the following day and another investigation took place 15 days later. Statistically significant effects ( p ??0.05) in the reduction of all signs and symptoms of chronic tonsillitis after KR treatment were observed. These results indicate that Kumarabharana Rasa has an ameliorative effect in reducing the signs and symptoms of chronic tonsillitis. Graphical abstract Display Omitted.
机译：在本研究中评估了阿育吠陀聚 - 培养育 - 矿物配方Kumarabharana Rasa（KR）在儿童慢性扁桃体炎（Tundikeri）管理中的影响。该临床研究是一项双臂研究，该研究是在一家位于印度南部地区总部的教学学院的第三级阿育吠陀医院的门诊水平上进行了一项双臂研究。患者（n？= 40），慢性扁桃体炎令人满意的诊断标准和5至10年的年龄在Hassan of Ayurvea和Housity，Hassan Humarbhritya的门诊部门。其中，将20名患者用Kumarabharana Rasa（片剂形式）以每日500μmg的剂量处理30天（A组）。另外20名患者用Dodhuma Vati（Placebo）以每日500μmg的剂量治疗30天（B组）。在这两个群体中，Madhu是Anupana建议的。完成30天治疗后，患者在第二天进行评估，另一次调查后15天后。在观察到KR治疗后，在减少慢性扁桃体炎的所有迹象和症状的统计学意义（p？0.05）。这些结果表明，Kumarabharana Rasa对降低慢性扁桃体炎的迹象和症状具有改进效果。省略了图形抽象显示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号